October 20, 2014 — Sony Electronics’ Medical Systems Division is highlighting four new medical printers at RSNA 2014: models UP-D898MD, UP-X898MD, UP-991AD and UP-971AD. Each new model is Food and Drug Administration (FDA) Class II, 510(k) cleared. The new printers are designed for increased efficiency and performance in a range of radiology applications, including ultrasound, portable C-Arm and cardiac cath labs.

Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. At least 65 percent of people with diabetes die from some form of heart disease or stroke, according to the American Heart Association.

Boston Scientific Corp. has received CE mark approval for the Accolade pacemaker family. 


Samsung Electronics America Inc. announced the preliminary results of a groundbreaking trial into the use of tablet-based ultrasound in emergency services vehicles.

Akers Biosciences Inc. has signed a feasibility study deal with Konica Minolta Inc. to develop a rapid test for the early detection of myocardial infarction. Heart attacks are the leading cause of death in United States, with approximately 1.1 million Americans suffering heart attacks each year.

The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care announces participation in a new Transatlantic Network of Excellence as part of a $6 million award from the Leducq Foundation. The Transatlantic Network of Excellence is made up of a team of researchers from around the world tasked with conducting first of its kind research on the genetic causes of atrial fibrillation (AF). The institute will serve as the coordinating site in the United States and Amsterdam Medical Center will serve as the coordinating site for Europe. The network will provide a platform for conducting cutting-edge and meaningful research into this common arrhythmia.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now